Vasovagal Syncope Clinical Trial
Official title:
Observation of ImageReady™ MR Conditional Pacing System in China
To observe the safety and efficacy of ImageReady™ MR Conditional Pacing System in Chinese subjects
Key Inclusion Criteria:
1. Subject must have the Image Ready System as their initial (de novo) pacing system
implant.
2. Subject has a Class I or II indication for implantation of a pacemaker according to the
CSPE guidelines.
3. Subject is able and willing to undergo an MR scan.•
4. Subject is willing and capable of providing informed consent and participating in all
testing/ visits associated with this clinical study at the intervals defined by this
protocol.
5. Subject is age 18 or above.
Key Exclusion Criteria
1. Subject has or has had any pacing or ICD system implants.
2. Subject has any implants or devices that are not suitable for MR scan.
3. Subject is enrolled in any other concurrent study that might interfere with this study.
4. Subject has documented life expectancy of less than 12 months.
5. Women of childbearing potential who are or might be pregnant at the time of this study.
Primary Safety Endpoint:
MR Scan related Complication Free Rate Analyzed at MRI Visit +1 Month.
Primary efficacy Endpoint:
1. Pacing Threshold (at 0.5 ms pulse width) comparison pre and 1 Month post MR Scan: pacing
threshold increase ≤ 0.5 V after scan.
2. Sensed Amplitude comparison pre- and 1 Month post-MR Scan: sensed amplitude: ≥ 1.0 mV
after scan, and ≥ 50% of that before scan.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05621460 -
The Effect of Water Carbonation on Orthostatic Tolerance
|
N/A | |
Active, not recruiting |
NCT02123056 -
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
|
Phase 4 | |
Completed |
NCT02140567 -
Syncope Prediction Study
|
||
Active, not recruiting |
NCT01456481 -
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV
|
Phase 4 | |
Completed |
NCT00061009 -
Hypnosis in Autonomic Function
|
N/A | |
Recruiting |
NCT06331819 -
Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
|
||
Recruiting |
NCT05159687 -
Study of Atomoxetine in the Prevention of Vasovagal Syncope
|
Phase 3 | |
Completed |
NCT02500732 -
Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
|
Phase 2 | |
Recruiting |
NCT02018497 -
Essential Hypotension and Allostasis Registry
|
||
Recruiting |
NCT03446326 -
Assessment of Stroke Volume and Cardiac Output in Response to Varying Heart Rates
|
N/A | |
Active, not recruiting |
NCT01791816 -
Mechanisms of Vasovagal Syncope
|
Early Phase 1 | |
Completed |
NCT00292825 -
Effect of Closed Loop Pacemaker Treatment on Recurrent Vasovagal Syncope
|
N/A | |
Completed |
NCT02949804 -
Relation Between Vasovagal Tendency and Smoking Among University Students
|
N/A | |
Completed |
NCT02009982 -
Cardioneuroablation for Neurocardiogenic Syncope
|
N/A | |
Not yet recruiting |
NCT06166277 -
Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry
|